Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.068 0.2
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.094 0.2
mRNA A-770041 GDSC1000 pan-cancer AAC -0.068 0.2
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.037 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.038 0.2
mRNA SB590885 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
Download CSV